Enabling Successful Sites, Episode 3: Taking the complexity out of oncology clinical trials
Oncology clinical trials present unique challenges for investigative sites, including complex trial designs, challenging eligibility criteria, and invasive procedures. In addition, the oversaturation of trials leads to competition for patients and experienced sites.
The third episode of Enabling Successful Sites features a discussion between Karen McIntyre (Vice President, Global Site Alliances), Mitch Carter (Associate Director, Global Site Alliances), and Angela Galindo, (Vice President, Client Engagement at START Network) as they talk about the competition for patients and experienced sites for oncology trials, why a site would pass on a study opportunity and how we can make oncology studies less burdensome for both patients and sites.
Episode 1: Site feasibility and study start-up challenges
Episode 2: Empowering sites to be more inclusive through cultural sensitivity training
Episode 4: Part 1: Partnering with sites to improve patient recruitment and retention
Episode 4: Part 2: Leveraging AI to improve patient recruitment and retention
Episode 5: Strategies for improving communication between sites, sponsors and CROs
Related Insights
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Blog
Studying rare cancer patient populations using integrated genomic and real-world data
Aug 30, 2023
Article
How a joined-up development strategy pays off for early-stage biotechs
May 19, 2021
Article
Key strategies to mitigate the risks of asthma drug development
Jan 24, 2025
Blog
Adapting the validation process for PROs for rare diseases and other diseases with large unmet need and/or rapid progression
Apr 23, 2024
Podcast
Enabling Successful Sites: Episode 5, Part One: Strategies for improving communication between sites, sponsors and CROs
Feb 24, 2025
Report
New Medicines, Novel Insights: Advancing Precision Oncology
May 14, 2024
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021
Blog
Scientific Advances: Catalyst for Biotech Investment and Innovation in Clinical Development
Mar 12, 2024
CTB Podcast
Pioneering oncology trials with AVEO Oncology
Mar 11, 2025
Article
4 Insights on decentralized trials for biotechs
Jul 1, 2021
Related Insights
Podcast
Enabling Successful Sites, Episode 2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Blog
Studying rare cancer patient populations using integrated genomic and real-world data
Aug 30, 2023
Article
How a joined-up development strategy pays off for early-stage biotechs
May 19, 2021
Article
Key strategies to mitigate the risks of asthma drug development
Jan 24, 2025
Blog
Adapting the validation process for PROs for rare diseases and other diseases with large unmet need and/or rapid progression
Apr 23, 2024
Podcast
Enabling Successful Sites: Episode 5, Part One: Strategies for improving communication between sites, sponsors and CROs
Feb 24, 2025
Report
New Medicines, Novel Insights: Advancing Precision Oncology
May 14, 2024
Blog
Master Protocol Trials: What Are the Elements of Success?
Dec 1, 2021
Blog
Scientific Advances: Catalyst for Biotech Investment and Innovation in Clinical Development
Mar 12, 2024
CTB Podcast
Pioneering oncology trials with AVEO Oncology
Mar 11, 2025
Article
4 Insights on decentralized trials for biotechs
Jul 1, 2021